Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Sanath Allampati"'
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 25, Iss 3, Pp 188-193 (2019)
Background/Aim: Most endoscopies performed in the United States utilize sedation. Anesthesia provides patient comfort and improved procedural quality but adds to the complexity of scheduling routine outpatient procedures. We aimed to assess the retur
Externí odkaz:
https://doaj.org/article/b75481a2596948d0bcc208a384e50ab0
Autor:
Jagpal Singh Klair, Kavish R. Patidar, James B. Wade, Christopher Flud, Leroy R. Thacker, Edith Gavis, Douglas M. Heuman, Melanie B. White, Sanath Allampati, Andres Duarte-Rojo, Jasmohan S. Bajaj
Publikováno v:
Metabolic Brain Disease. 34:289-295
BACKGROUND & AIMS: Covert hepatic encephalopathy (CHE) affects cognition in a multidimensional fashion. Current guidelines recommend performing Psychometric Hepatic Encephalopathy Score (PHES) and a second test to diagnose CHE for multi-center trials
Autor:
Alessio Farcomeni, J.S. Bajaj, Oliviero Riggio, Stefania Gioia, James B. Wade, Ariel Unser, Silvia Nardelli, Melanie B. White, Sanath Allampati, R. Prakash, Edith Gavis, Andrew J. Fagan, Kevin D. Mullen
Publikováno v:
Digestive Diseases and Sciences. 62:794-800
Hepatic encephalopathy (HE) is considered reversible regarding mental status but may not be cognitively in single-center studies. To evaluate persistence of learning impairment in prior HE compared to those who never experienced HE (no-HE) in a multi
Autor:
Andres Duarte-Rojo, Leroy R. Thacker, Christopher Flud, Edith Gavis, Binu John, Melanie B. White, Sanath Allampati, Robert O'Shea, James B. Wade, Jagpal Singh Klair, Jasmohan S. Bajaj, Douglas M. Heuman, Ariel Unser, Kavish R. Patidar
Publikováno v:
American Journal of Gastroenterology. 111:78-86
Diagnosing minimal hepatic encephalopathy (MHE) is challenging, and point-of-care tests are needed. Stroop EncephalApp has been validated for MHE diagnosis in single-center studies. The objective of the study was to validate EncephalApp for MHE diagn
Autor:
Sanath Allampati, Helen M. Ayles, Bruce R. Bacon, Sarah Lou Bailey, William F. Balistreri, Ji Young Bang, Petros C. Benias, Marina Berenguer, Emily D. Bethea, Kalyan Ram Bhamidimarri, Christopher L. Bowlus, Andres Cardenas, Andres F. Carrion, Steve S. Choi, Sanjiv Chopra, Raymond T. Chung, Jeremy F.L. Cobbold, Michael P. Curry, Albert J. Czaja, Teresita Gomez de Castro, Andrew S. deLemos, Adrian M. Di Bisceglie, Anna Mae Diehl, Robert J. Fontana, Lawrence S. Friedman, Pere Ginès, Norman D. Grace, Steven-Huy B. Han, Gideon M. Hirschfield, Michael G. House, Christine E. Waasdorp Hurtado, Ira M. Jacobson, Kris V. Kowdley, Michelle Lai, Jay H. Lefkowitch, Chatmanee Lertudomphonwanit, James H. Lewis, Keith D. Lillemoe, Vincent Lo Re, Hanisha Manickavasagan, Paul Martin, Marlyn J. Mayo, Mack C. Mitchell, Kevin D. Mullen, Santiago J. Muñoz, Brent A. Neuschwander-Tetri, Kelvin T. Nguyen, Kavish R. Patidar, Patricia Pringle, Nicholas J. Procaccini, James Puleo, K. Rajender Reddy, Hugo R. Rosen, Arun J. Sanyal, Michael L. Schilsky, Stuart Sherman, Ronald J. Sokol, Erin Spengler, Elena M. Stoffel, John A. Summerfield, Elliot B. Tapper, Tram T. Tran, Carmen Vinaixa, Gwilym J. Webb, Douglas M. Weine, Jacqueline L. Wolf, Florence S. Wong, Wei Zhang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8261292322a03b79a9bdf9b1eee08112
https://doi.org/10.1016/b978-0-323-47874-8.01002-6
https://doi.org/10.1016/b978-0-323-47874-8.01002-6
Publikováno v:
Current Hepatology Reports. 14:19-24
Interest in covert hepatic encephalopathy (CHE) has been increasing steadily for decades among clinicians. The term covert had to be substituted for minimal because minimal hepatic encephalopathy (MHE) did not signify the importance of this disorder.
Autor:
Sanath, Allampati, Kevin D, Mullen
Publikováno v:
Minerva gastroenterologica e dietologica. 62(4)
Hepatic encephalopathy (HE) is a complex neuropsychiatric syndrome associated with decompensated liver disease. The spectrum of disease ranges from trivial abnormalities in complex decision-making and prolonged reaction time to coma in its most sever
Use of a positional therapy device significantly improves nocturnal gastroesophageal reflux symptoms
Publikováno v:
Diseases of the Esophagus.
The aim of this study was to measure the efficacy of a positional therapy device (PTD) at reducing proton pump inhibitor (PPI) refractory nocturnal GERD symptoms. Among patients with GERD, nocturnal symptoms are very common. A recent study demonstrat
Publikováno v:
The Journal of family practice. 65(4)
Lifestyle changes and metabolic syndrome management are the best interventions for NAFLD. Less clear is which agents to use for liver-directed pharmacotherapy.